ArticleClinical pharmacokinetics2006

An extended terminal half-life for darbepoetin alfa: results from a single-dose pharmacokinetic study in patients with chronic kidney disease not receiving dialysis.

Desmond Padhi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.